Literature DB >> 8093549

Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study.

L Edwards1, E M Quigley, R Hofman, R F Pfeiffer.   

Abstract

In a recent study we identified abnormal salivation, dysphagia, nausea, constipation, and defecatory dysfunction as those gastrointestinal (GI) symptoms associated with Parkinson disease (PD) and characterized their relationship to PD severity and therapy. In this study, we re-evaluated these symptoms and their relationship to parameters of PD 18 months later. Sixty-six percent of the original participants responded. Over the 18 months, 68% of originally untreated PD subjects commenced anti-PD therapy. Abnormal salivation, dysphagia, nausea, constipation, and defecatory dysfunction were again identified as those GI symptoms more common in PD. Constipation increased both in severity and frequency. Comparison of GI symptom scores and parameters of PD dysfunction failed to reveal significant progression of either GI symptomatology or PD dysfunction, or the development of new GI symptoms over the 18-month period. This study validates our GI dysfunction assessment system and confirms abnormal salivation, dysphagia, nausea, constipation, and defecatory function as those GI symptoms truly associated with PD. A direct relationship between PD and its related GI symptoms is again supported.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093549     DOI: 10.1002/mds.870080115

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

Review 1.  Gastrointestinal features of Parkinson's disease.

Authors:  Leslie J Cloud; James G Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 2.  [Nonmotor symptoms in Parkinson's disease].

Authors:  W H Jost
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

3.  The Gut Microbiome and Mental Health: What Should We Tell Our Patients?: Le microbiote Intestinal et la Santé Mentale : que Devrions-Nous dire à nos Patients?

Authors:  Mary I Butler; Sabrina Mörkl; Kiran V Sandhu; John F Cryan; Timothy G Dinan
Journal:  Can J Psychiatry       Date:  2019-09-17       Impact factor: 4.356

Review 4.  Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management.

Authors:  W H Jost
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

5.  Neurotoxin-Induced Catecholaminergic Loss in the Colonic Myenteric Plexus of Rhesus Monkeys.

Authors:  Jeanette M Shultz; Henry Resnikoff; Viktorya Bondarenko; Valerie Joers; Andres Mejia; Heather Simmons; Marina E Emborg
Journal:  J Alzheimers Dis Parkinsonism       Date:  2016-11-03

Review 6.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

7.  Impaired gastric myoelectrical activity in patients with Parkinson's disease and effect of levodopa treatment.

Authors:  Ching-Liang Lu; Din-E Shan; Chih-Yen Chen; Jiing-Chyuan Luo; Full-Young Chang; Shou-Dong Lee; Han-Chang Wu; J D Z Chen
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

Review 8.  [Gastrointestinal dysfunction in idiopathic Parkinson's disease].

Authors:  K Del Tredici; W H Jost
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

Review 9.  Dysphagia in Parkinson's Disease.

Authors:  Inga Suttrup; Tobias Warnecke
Journal:  Dysphagia       Date:  2015-11-21       Impact factor: 3.438

10.  Evaluation of gastric emptying in familial and sporadic Parkinson disease.

Authors:  Anna Krygowska-Wajs; William P Cheshire; Zbigniew K Wszolek; Alicja Hubalewska-Dydejczyk; Barbara Jasinska-Myga; Matthew J Farrer; Marek Moskala; Anna Sowa-Staszczak
Journal:  Parkinsonism Relat Disord       Date:  2009-05-17       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.